bluebird bio Inc (NAS:BLUE)
$ 0.9634 0.06 (6.64%) Market Cap: 185.69 Mil Enterprise Value: 303.88 Mil PE Ratio: 0 PB Ratio: 0.46 GF Score: 25/100

bluebird bio Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa Transcript

Oct 02, 2019 / 06:30PM GMT
Release Date Price: $55.96 (-0.66%)
Unidentified Analyst

Thanks, Pascal. Now it's bluebird time with Jeff Walsh; Jeff's Chief Strategic Officer.

Jeffrey T. Walsh
bluebird bio, Inc. - Chief Strategy Officer

Good morning. I'm excited to be here. And it is bluebird time, I guess for the next 15 minutes at least.

So one of things that we've talked about as a company, and really, focused on throughout the history of the company is this concept of recoding. And this is the case for all of us in this field. We really have to change systems. We have to change the way we're developing these therapies, the way that we're delivering these therapies. And that's really where we are as a company right now, not only on the research side, development side, but now having to recode on the commercial side. So it's a really exciting time for us for sure.

I will be making forward-looking statements as well, so please refer to the SEC filings for more information on that in terms of the risks of the company.

When we talk about recoding for life is conveyed on this slide. It's the middle part of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot